{
    "2018-08-03": [
        [
            {
                "time": "2018-07-26",
                "original_text": "Analysts Raise Target Prices for TEVA after Its Q2 2018 Results",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Raise",
                        "Target Prices",
                        "TEVA",
                        "Q2 2018 Results"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "What Pushed Teva’s Earnings Above Analysts’ Estimate",
                "features": {
                    "keywords": [
                        "Teva",
                        "Earnings",
                        "Above",
                        "Analysts' Estimate"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "Teva Falls 9.5% as Q2 Sales Miss Analysts’ Estimate",
                "features": {
                    "keywords": [
                        "Teva",
                        "Falls",
                        "9.5%",
                        "Q2 Sales",
                        "Miss",
                        "Analysts' Estimate"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "Eli Lilly Breaks Out of a Large Consolidation Pattern, Further Gains Ahead",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Breaks Out",
                        "Consolidation Pattern",
                        "Further Gains Ahead"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "United Therapeutics: Analyst Recommendations, Product Performance",
                "features": {
                    "keywords": [
                        "United Therapeutics",
                        "Analyst Recommendations",
                        "Product Performance"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "Eli Lilly’s Q2 2018 Earnings: Key Developments",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Q2 2018 Earnings",
                        "Key Developments"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "Eli Lilly’s Q2 2018 Earnings: Elanco",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Q2 2018 Earnings",
                        "Elanco"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "The Daily Biotech Pulse: Zafgen Executive Departs; Adamas, Acceleron Accelerate On Earnings",
                "features": {
                    "keywords": [
                        "Biotech Pulse",
                        "Zafgen",
                        "Executive Departs",
                        "Adamas",
                        "Acceleron",
                        "Earnings"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "Eli Lilly’s Q2 2018 Earnings: New Products",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Q2 2018 Earnings",
                        "New Products"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-26",
                "original_text": "Jim Cramer: 4 Pet-Related Stocks That Are Top Dog",
                "features": {
                    "keywords": [
                        "Jim Cramer",
                        "Pet-Related Stocks",
                        "Top Dog"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "consumer goods"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}